80 FR 46322 - Adeline Davies Essien, M.D.; Decision and Order

DEPARTMENT OF JUSTICE
Drug Enforcement Administration

Federal Register Volume 80, Issue 149 (August 4, 2015)

Page Range		46322-46323
FR Document		2015-19122
Federal Register, Volume 80 Issue 149 (Tuesday, August 4, 2015)
[Federal Register Volume 80, Number 149 (Tuesday, August 4, 2015)]
[Notices]
[Pages 46322-46323]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-19122]


-----------------------------------------------------------------------

 DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. 15-15]


Adeline Davies Essien, M.D.; Decision and Order

    On March 25, 2015, Administrative Law Judge (ALJ) Christopher B. 
McNeil issued the attached Recommended Decision. Neither party filed 
exceptions to the Recommended Decision.
    Having reviewed the record in its entirety, I adopt the ALJ's 
findings of fact, conclusions of law and recommended order.\1\ 
Accordingly, I will order that Respondent's DEA Certificate of 
Registration be revoked and that any pending application to renew or 
modify her registration be denied.
---------------------------------------------------------------------------

    \1\ I take official notice of the fact that, according to the 
registration records of the Agency, Respondent retains an active 
registration as of this date. Pursuant to 21 CFR 1316.59(e), 
Respondent may controvert this finding by filing a properly 
supported motion, no later than 10 days from the date of this Order.
---------------------------------------------------------------------------

Order

    Pursuant to the authority vested in me by 21 U.S.C. 823(f) and 
824(a)(3), as well as 28 CFR 0.100(b), I order that DEA Certificate of 
Registration BE6969541, issued to Adeline Davies Essien, M.D., be, and 
it hereby is, revoked. I further order that any pending application of 
Adeline Davies Essien, M.D., to renew or modify her registration, be, 
and it hereby is, denied. This Order is effective September 3, 2015.

    Dated: July 27, 2015.
Chuck Rosenberg,
Acting Administrator.

Frank W. Mann, Esq., for the Government.
Thomas P. O'Connell, Esq., for the Respondent.

ORDER GRANTING THE GOVERNMENT'S MOTION FOR SUMMARY DISPOSITION and 
FINDINGS OF FACT, CONCLUSIONS OF LAW, AND RECOMMENDED DECISION OF THE 
ADMINISTRATIVE LAW JUDGE

    Administrative Law Judge Christopher B. McNeil. On January 21, 
2015, the Deputy Assistant Administrator of the Drug Enforcement 
Administration (DEA) issued an Order to Show Cause as to why the DEA 
should not revoke DEA Certificate of Registration Number BE6969541 
issued to Adeline Davies Essien, M.D., the Respondent in this matter. 
The Order seeks to revoke Respondent's registration pursuant to 21 
U.S.C. 824(a)(4) and 823(f), and to deny any pending applications for 
renewal or modification of such registration, and deny any applications 
for any new DEA registrations pursuant to 21 U.S.C. 823(f). As grounds 
for denial, the Government alleges that Respondent is ``currently 
without authority to handle controlled substances in the State of 
Illinois, the state in which [Respondent is] registered with the DEA.''
    On February 27, 2015, the DEA's Office of Administrative Law Judges 
received Respondent's written request for a hearing, which is dated 
February 26, 2015. Respondent stated that she objected to the 
Government's allegation regarding Respondent's authority to handle 
controlled substances. Respondent further stated that she ``does have 
authority to practice medicine and handle controlled substances.''
    On March 3, 2015, this Office issued an Order for Briefing on 
Allegations Concerning Respondent's Lack of State Authority, Order for 
Prehearing Statements, and Order Setting the Matter for Hearing. In the 
Order, I mandated that the parties provide briefs regarding the 
allegation that Respondent lacks state authority to handle controlled 
substances no later than 2:00 p.m. on March 17, 2015. In my Order, I 
also provided that responses to any briefs be submitted by no later 
than 2:00 p.m. on March 24, 2015. On March 17, 2015, I timely received 
the Government's Response to Order and Motion for Summary Disposition. 
According to the Government's motion,

[[Page 46323]]

Respondent is without authority to prescribe, administer, or dispense 
controlled substances in the State of Illinois. In its Exhibit One 
attachment, the Government provided evidence that the State of 
Illinois, the jurisdiction where she is licensed to practice medicine 
and where Respondent is registered with the DEA, considers her license 
``Not Renewed'' with an expiration date of July 31, 2014. Additionally, 
the Government in its Exhibit Two attachment provided a sworn 
declaration of Laura Forester, Chief of Medical Prosecutions for the 
Illinois Department of Financial and Professional Regulation, stating 
that Respondent is not currently authorized under Illinois law to 
handle controlled substances. Based on this status, the Government 
moved for a summary disposition of these proceedings as well as a stay 
of these proceedings pending resolution of its Motion for Summary 
Disposition. Finding good cause was shown, I granted an Order Staying 
Proceedings with the exception of the March 24, 2015 deadline for 
Respondent's response to the Government's Motion for Summary 
Disposition.
    Respondent filed a timely response to the Government's Motion for 
Summary Disposition on March 24, 2015. In her response, Respondent 
states that her Illinois State medical license case is pending appeal 
and is therefore not a final disposition. Respondent further attached 
an affidavit affirming that she has a case pending before the Illinois 
Administrative Law Court that is pending appeal. She also attached 
``Exhibit B'' containing a statement from Lillian Walanka, who is 
representing Respondent before the Illinois Administrative Law Court. 
Ms. Walanka again confirms that the case is pending final action by 
Illinois authorities. Ms. Walanka states that although Respondent filed 
a timely renewal application of her controlled substances license, her 
controlled substances license was not renewed pending a Notice of 
Intent to Refuse to Renew by authorities in Illinois.
    The substantial issue raised by the Government rests on an 
undisputed fact. The Government asserts that Respondent's DEA 
Certificate of Registration must be revoked because Respondent does not 
have an active controlled substance registration issued by the state in 
which she practices. Under DEA precedent, a practitioner's DEA 
Certificate of Registration for controlled substances must be summarily 
revoked if the applicant is not authorized to handle controlled 
substances in the state in which she maintains her DEA registration.\2\ 
Pursuant to 21 U.S.C. 823(f), only a ``practitioner'' may receive a DEA 
registration. Under 21 U.S.C. 802(21), a ``practitioner'' must be 
``licensed, registered, or otherwise permitted, by the United States or 
the jurisdiction in which he practices or does research, to distribute 
[or] dispense . . . controlled substance[s.]'' Given this statutory 
language, the DEA Administrator does not have the authority under the 
Controlled Substances Act to maintain a practitioner's registration if 
that practitioner is not authorized to dispense controlled 
substances.\3\
---------------------------------------------------------------------------

    \2\ See 21 U.S.C. 801(21), 823(f), 824(a)(3); see also House of 
Medicine, 79 FR 4959, 4961 (DEA Jan. 30, 2014); Deanwood Pharmacy, 
68 FR 41662-01 (DEA July 14, 2003); Wayne D. Longmore, M.D., 77 FR 
67669-02 (DEA Nov. 13, 2012); Alan H. Olefsky, M.D., 72 FR 42127-01 
(DEA Aug. 1, 2007); Layfe Robert Anthony, M.D., 67 FR 15811 (DEA May 
20, 2002); George Thomas, PA-C, 64 FR 15811-02 (DEA Apr. 1, 1999); 
Shahid Musud Siddiqui, M.D., 61 FR 14818-02 (DEA April 4, 1996); 
Michael D. Lawton, M.D., 59 FR 17792-01 (DEA Apr. 14, 1994); Abraham 
A. Chaplan, M.D., 57 FR 55280-03 (DEA Nov. 24, 1992). See also Bio 
Diagnosis Int'l, 78 FR 39327-03, 39331 (DEA July 1, 2013) 
(distinguishing distributor applicants from other ``practitioners'' 
in the context of summary disposition analysis).
    \3\ See Abraham A. Chaplan, M.D., 57 FR 55280-03, 55280 (DEA 
Nov. 24, 1992), and cases cited therein. In Chaplan, DEA 
Administrator Robert C. Bonner adopts the ALJ's opinion that ``the 
DEA lacks statutory power to register a practitioner unless the 
practitioner holds state authority to handle controlled 
substances.'' Id.
---------------------------------------------------------------------------

    Respondent correctly argues in her response that a final 
disposition has not been made regarding her controlled substance 
registration in Illinois's administrative proceedings. However, 
Respondent mischaracterizes the Government's Motion for Summary 
Disposition when alleging that the Government is arguing that a final 
disposition had occurred. The Government is only arguing that 
Respondent is currently without authority to handle controlled 
substances in Illinois. To emphasize this point, the Government cites 
to the case of Roger A. Rodriguez, M.D. to demonstrate that even a 
temporary suspension warrants revocation.\4\ As DEA Administrator 
Michele M. Leonhart previously stated in James L. Hooper, M.D., ``the 
controlling question is not whether a practitioner's license to 
practice medicine in the state is suspended or revoked; rather, it is 
whether the Respondent is currently authorized to handle controlled 
substances in the state.'' \5\ In Hooper, Administrator Leonhart 
concluded that ``even where a practitioner's state license has been 
suspended for a period of certain duration, the practitioner no longer 
meets the statutory definition of a practitioner.'' \6\ In this case, 
Respondent's state controlled substance registration has been suspended 
for an indefinite duration. As detailed above, only a ``practitioner'' 
may receive a DEA registration. Therefore, I will recommend the 
revocation of Respondent's DEA registration.
---------------------------------------------------------------------------

    \4\ Roger A. Rodriguez, M.D., 70 FR 33206, 33,207 (DEA June 7, 
2005).
    \5\ James L. Hooper, M.D.; Decision and Order, 76 FR 71371-01, 
71371 (DEA Nov. 17, 2011).
    \6\ Id. at 71372.
---------------------------------------------------------------------------

Order Granting the Government's Motion for Summary Disposition and 
Recommendation

    I find there is no genuine dispute regarding whether Respondent is 
a ``practitioner'' as that term is defined by 21 U.S.C. 802(21), and 
that based on the record the Government has established that Respondent 
is not a practitioner and is not authorized to dispense controlled 
substances in the state in which she seeks to practice with a DEA 
Certificate of Registration. I find no other material facts at issue. 
Accordingly, I GRANT the Government's Motion for Summary Disposition.
    Upon this finding, I ORDER that this case be forwarded to the 
Administrator for final disposition and I recommended that Respondent's 
DEA Certificate of Registration should be REVOKED and any pending 
application for the renewal or modification of the same should be 
DENIED.

    Dated: March 25, 2015
Christopher B. McNeil,
Administrative Law Judge.
[FR Doc. 2015-19122 Filed 8-3-15; 8:45 am]
BILLING CODE 4410-09-P
46322 Federal Register / Vol. 80, No. 149 / Tuesday, August 4, 2015 / Notices

Issued: July 29, 2015. Controlled substance Schedule Dated: July 27, 2015.
Lisa R. Barton, Chuck Rosenberg,
Secretary to the Commission. Poppy Straw Concentrate (9670) II Acting Administrator.
[FR Doc. 2015–18984 Filed 8–3–15; 8:45 am] Fentanyl (9801) ............................ II
Frank W. Mann, Esq., for the
BILLING CODE 7020–02–P Government.
The company plans to import Thomas P. O’Connell, Esq., for the
thebaine derivatives and fentanyl as Respondent.
DEPARTMENT OF JUSTICE reference standards.
ORDER GRANTING THE
The company plans to import the GOVERNMENT’S MOTION FOR
Drug Enforcement Administration remaining listed controlled substances SUMMARY DISPOSITION and
[Docket No. DEA–392] as raw materials, to be used in the FINDINGS OF FACT, CONCLUSIONS
manufacture of bulk controlled OF LAW, AND RECOMMENDED
Importer of Controlled Substances substances, for distribution to its DECISION OF THE ADMINISTRATIVE
Registration: Johnson Matthey, Inc. customers. LAW JUDGE
ACTION: Notice of registration. Dated: July 29, 2015. Administrative Law Judge
Joseph T. Rannazzisi, Christopher B. McNeil. On January 21,
SUMMARY: Johnson Matthey, Inc. applied
Deputy Assistant Administrator. 2015, the Deputy Assistant
to be registered as an importer of certain
[FR Doc. 2015–19107 Filed 8–3–15; 8:45 am] Administrator of the Drug Enforcement
basic classes of controlled substances.
Administration (DEA) issued an Order
The Drug Enforcement Administration BILLING CODE 4410–09–P
to Show Cause as to why the DEA
(DEA) grants Johnson Matthey, Inc.,
should not revoke DEA Certificate of
registration as an importer of those
DEPARTMENT OF JUSTICE Registration Number BE6969541 issued
controlled substances.
to Adeline Davies Essien, M.D., the
SUPPLEMENTARY INFORMATION: By notice Respondent in this matter. The Order
dated April 14, 2015, and published in Drug Enforcement Administration
seeks to revoke Respondent’s
the Federal Register on April 22, 2015, registration pursuant to 21 U.S.C.
80 FR 22559, Johnson Matthey, Inc., [Docket No. 15–15]
824(a)(4) and 823(f), and to deny any
Pharmaceutical Materials, 2003 Nolte pending applications for renewal or
Drive, West Deptford, New Jersey Adeline Davies Essien, M.D.; Decision
modification of such registration, and
08066–1742 applied to be registered as and Order
deny any applications for any new DEA
an importer of certain basic classes of registrations pursuant to 21 U.S.C.
controlled substances. No comments or On March 25, 2015, Administrative
Law Judge (ALJ) Christopher B. McNeil 823(f). As grounds for denial, the
objections were submitted for this Government alleges that Respondent is
notice. Comments and requests for issued the attached Recommended
‘‘currently without authority to handle
hearings on applications to import Decision. Neither party filed exceptions
controlled substances in the State of
narcotic raw material are not to the Recommended Decision. Illinois, the state in which [Respondent
appropriate. 72 FR 3417, (January 25, Having reviewed the record in its is] registered with the DEA.’’
2007). entirety, I adopt the ALJ’s findings of On February 27, 2015, the DEA’s
The DEA has considered the factors in fact, conclusions of law and Office of Administrative Law Judges
21 U.S.C. 823, 952(a) and 958(a) and recommended order.1 Accordingly, I received Respondent’s written request
determined that the registration of will order that Respondent’s DEA for a hearing, which is dated February
Johnson Matthey, Inc. to import the 26, 2015. Respondent stated that she
Certificate of Registration be revoked
basic classes of controlled substances is objected to the Government’s allegation
and that any pending application to
consistent with the public interest and regarding Respondent’s authority to
renew or modify her registration be
with United States obligations under handle controlled substances.
international treaties, conventions, or denied.
Respondent further stated that she
protocols in effect on May 1, 1971. The Order ‘‘does have authority to practice
DEA investigated the company’s medicine and handle controlled
maintenance of effective controls Pursuant to the authority vested in me
substances.’’
against diversion by inspecting and by 21 U.S.C. 823(f) and 824(a)(3), as On March 3, 2015, this Office issued
testing the company’s physical security well as 28 CFR 0.100(b), I order that an Order for Briefing on Allegations
systems, verifying the company’s DEA Certificate of Registration Concerning Respondent’s Lack of State
compliance with state and local laws, BE6969541, issued to Adeline Davies Authority, Order for Prehearing
and reviewing the company’s Essien, M.D., be, and it hereby is, Statements, and Order Setting the
background and history. revoked. I further order that any Matter for Hearing. In the Order, I
Therefore, pursuant to 21 U.S.C. pending application of Adeline Davies mandated that the parties provide briefs
952(a) and 958(a), and in accordance Essien, M.D., to renew or modify her regarding the allegation that Respondent
with 21 CFR 1301.34, the above-named registration, be, and it hereby is, denied. lacks state authority to handle
company is granted registration as an This Order is effective September 3, controlled substances no later than 2:00
importer of the basic classes controlled 2015. p.m. on March 17, 2015. In my Order,
substances:
tkelley on DSK3SPTVN1PROD with NOTICES

I also provided that responses to any
1 I take official notice of the fact that, according briefs be submitted by no later than 2:00
Controlled substance Schedule
to the registration records of the Agency, p.m. on March 24, 2015. On March 17,
Respondent retains an active registration as of this 2015, I timely received the
Coca Leaves (9040) ..................... II date. Pursuant to 21 CFR 1316.59(e), Respondent
Thebaine (9333) ........................... II may controvert this finding by filing a properly
Government’s Response to Order and
Opium, raw (9600) ....................... II supported motion, no later than 10 days from the Motion for Summary Disposition.
Noroxymorphone (9668) .............. II date of this Order. According to the Government’s motion,

VerDate Sep<11>2014 18:45 Aug 03, 2015 Jkt 235001 PO 00000 Frm 00089 Fmt 4703 Sfmt 4703 E:\FR\FM\04AUN1.SGM 04AUN1
Federal Register / Vol. 80, No. 149 / Tuesday, August 4, 2015 / Notices 46323

Respondent is without authority to maintains her DEA registration.2 of certain duration, the practitioner no
prescribe, administer, or dispense Pursuant to 21 U.S.C. 823(f), only a longer meets the statutory definition of
controlled substances in the State of ‘‘practitioner’’ may receive a DEA a practitioner.’’ 6 In this case,
Illinois. In its Exhibit One attachment, registration. Under 21 U.S.C. 802(21), a Respondent’s state controlled substance
the Government provided evidence that ‘‘practitioner’’ must be ‘‘licensed, registration has been suspended for an
the State of Illinois, the jurisdiction registered, or otherwise permitted, by indefinite duration. As detailed above,
where she is licensed to practice the United States or the jurisdiction in only a ‘‘practitioner’’ may receive a DEA
medicine and where Respondent is which he practices or does research, to registration. Therefore, I will
registered with the DEA, considers her distribute [or] dispense . . . controlled recommend the revocation of
license ‘‘Not Renewed’’ with an substance[s.]’’ Given this statutory Respondent’s DEA registration.
expiration date of July 31, 2014. language, the DEA Administrator does
Additionally, the Government in its not have the authority under the Order Granting the Government’s
Exhibit Two attachment provided a Controlled Substances Act to maintain a Motion for Summary Disposition and
sworn declaration of Laura Forester, practitioner’s registration if that Recommendation
Chief of Medical Prosecutions for the practitioner is not authorized to I find there is no genuine dispute
Illinois Department of Financial and dispense controlled substances.3 regarding whether Respondent is a
Professional Regulation, stating that Respondent correctly argues in her ‘‘practitioner’’ as that term is defined by
Respondent is not currently authorized response that a final disposition has not 21 U.S.C. 802(21), and that based on the
under Illinois law to handle controlled been made regarding her controlled record the Government has established
substances. Based on this status, the substance registration in Illinois’s that Respondent is not a practitioner
Government moved for a summary administrative proceedings. However, and is not authorized to dispense
disposition of these proceedings as well Respondent mischaracterizes the controlled substances in the state in
as a stay of these proceedings pending Government’s Motion for Summary which she seeks to practice with a DEA
resolution of its Motion for Summary Disposition when alleging that the Certificate of Registration. I find no
Disposition. Finding good cause was Government is arguing that a final other material facts at issue.
shown, I granted an Order Staying disposition had occurred. The Accordingly, I GRANT the
Proceedings with the exception of the Government is only arguing that Government’s Motion for Summary
March 24, 2015 deadline for Respondent is currently without Disposition.
Respondent’s response to the authority to handle controlled Upon this finding, I ORDER that this
Government’s Motion for Summary substances in Illinois. To emphasize this case be forwarded to the Administrator
Disposition. point, the Government cites to the case for final disposition and I recommended
Respondent filed a timely response to of Roger A. Rodriguez, M.D. to that Respondent’s DEA Certificate of
the Government’s Motion for Summary demonstrate that even a temporary Registration should be REVOKED and
Disposition on March 24, 2015. In her suspension warrants revocation.4 As any pending application for the renewal
response, Respondent states that her DEA Administrator Michele M. or modification of the same should be
Illinois State medical license case is Leonhart previously stated in James L. DENIED.
pending appeal and is therefore not a Hooper, M.D., ‘‘the controlling question
Dated: March 25, 2015
final disposition. Respondent further is not whether a practitioner’s license to
attached an affidavit affirming that she practice medicine in the state is Christopher B. McNeil,
has a case pending before the Illinois suspended or revoked; rather, it is Administrative Law Judge.
Administrative Law Court that is whether the Respondent is currently [FR Doc. 2015–19122 Filed 8–3–15; 8:45 am]
pending appeal. She also attached authorized to handle controlled BILLING CODE 4410–09–P
‘‘Exhibit B’’ containing a statement from substances in the state.’’ 5 In Hooper,
Lillian Walanka, who is representing Administrator Leonhart concluded that
Respondent before the Illinois ‘‘even where a practitioner’s state DEPARTMENT OF JUSTICE
Administrative Law Court. Ms. Walanka license has been suspended for a period
again confirms that the case is pending Drug Enforcement Administration
final action by Illinois authorities. Ms. 2 See 21 U.S.C. 801(21), 823(f), 824(a)(3); see also [Docket No. DEA–392]
Walanka states that although House of Medicine, 79 FR 4959, 4961 (DEA Jan. 30,
2014); Deanwood Pharmacy, 68 FR 41662–01 (DEA
Respondent filed a timely renewal July 14, 2003); Wayne D. Longmore, M.D., 77 FR Manufacturer of Controlled
application of her controlled substances 67669–02 (DEA Nov. 13, 2012); Alan H. Olefsky, Substances Registration: Sigma
license, her controlled substances M.D., 72 FR 42127–01 (DEA Aug. 1, 2007); Layfe Aldrich Research Biochemicals, Inc.
license was not renewed pending a Robert Anthony, M.D., 67 FR 15811 (DEA May 20,
2002); George Thomas, PA–C, 64 FR 15811–02 ACTION: Notice of registration.
Notice of Intent to Refuse to Renew by (DEA Apr. 1, 1999); Shahid Musud Siddiqui, M.D.,
authorities in Illinois. 61 FR 14818–02 (DEA April 4, 1996); Michael D.
The substantial issue raised by the Lawton, M.D., 59 FR 17792–01 (DEA Apr. 14, 1994);
SUMMARY: Sigma Aldrich Research
Government rests on an undisputed fact. Abraham A. Chaplan, M.D., 57 FR 55280–03 (DEA Biochemicals, Inc. applied to be
The Government asserts that
Nov. 24, 1992). See also Bio Diagnosis Int’l, 78 FR registered as a manufacturer of certain
39327–03, 39331 (DEA July 1, 2013) (distinguishing basic classes of controlled substances.
Respondent’s DEA Certificate of distributor applicants from other ‘‘practitioners’’ in
Registration must be revoked because the context of summary disposition analysis). The Drug Enforcement Administration
Respondent does not have an active 3 See Abraham A. Chaplan, M.D., 57 FR 55280– (DEA) grants Sigma Aldrich Research
controlled substance registration issued 03, 55280 (DEA Nov. 24, 1992), and cases cited Biochemicals, Inc. registration as a
therein. In Chaplan, DEA Administrator Robert C. manufacturer of those controlled
tkelley on DSK3SPTVN1PROD with NOTICES

by the state in which she practices. Bonner adopts the ALJ’s opinion that ‘‘the DEA
Under DEA precedent, a practitioner’s lacks statutory power to register a practitioner
substances.
DEA Certificate of Registration for unless the practitioner holds state authority to SUPPLEMENTARY INFORMATION: By notice
handle controlled substances.’’ Id.
controlled substances must be 4 Roger A. Rodriguez, M.D., 70 FR 33206, 33,207
dated April 14, 2015, and published in
summarily revoked if the applicant is (DEA June 7, 2005). the Federal Register on April 22, 2015,
not authorized to handle controlled 5 James L. Hooper, M.D.; Decision and Order, 76

substances in the state in which she FR 71371–01, 71371 (DEA Nov. 17, 2011). 6 Id. at 71372.

VerDate Sep<11>2014 18:45 Aug 03, 2015 Jkt 235001 PO 00000 Frm 00090 Fmt 4703 Sfmt 4703 E:\FR\FM\04AUN1.SGM 04AUN1
Document Created: 2015-12-18 14:51:57
Document Modified: 2015-12-18 14:51:57
Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
FR Citation		80 FR 46322
80 FR 46322 - Adeline Davies Essien, M.D.; Decision and Order

DEPARTMENT OF JUSTICEDrug Enforcement Administration

Federal Register Volume 80, Issue 149 (August 4, 2015)

DEPARTMENT OF JUSTICE
Drug Enforcement Administration
